|
Cevac MD HVT
|
-
|
V/DCP/16/0037
|
Ceva-Phylaxia Co.Ltd., Ungārija
|
QI01AD03
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension and diluent for suspension for injection
|
| International name (active substance): |
Live Turkey Herpes virus
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
| Date of authorisation/renewal: |
29-Nov-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 26112021LI (26-Nov-2021)
|
| Labelling text: |
[DOCX] 26112021M (26-Nov-2021)
|
| Summary of product characteristics: |
[DOCX] 26112021ZA (26-Nov-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/16/0037-01 |
|
1 |
Ampula, 500 deva |
-
|
| V/DCP/16/0037-02 |
|
1 |
Ampula, 1000 deva |
-
|
| V/DCP/16/0037-03 |
|
1 |
Ampula, 2000 deva |
-
|
| V/DCP/16/0037-04 |
|
1 |
Ampula, 4000 deva |
-
|
| V/DCP/16/0037-05 |
|
1 |
Maiss (šķīdinātājs), 200 ml |
-
|
| V/DCP/16/0037-06 |
|
1 |
Maiss (šķīdinātājs), 400 ml |
-
|
| V/DCP/16/0037-07 |
|
1 |
Maiss (šķīdinātājs), 800 ml |
-
|
| V/DCP/16/0037-08 |
|
1 |
Maiss (šķīdinātājs), 1000 ml |
-
|
| V/DCP/16/0037-09 |
|
1 |
Maiss (šķīdinātājs), 1200 ml |
-
|
| V/DCP/16/0037-10 |
|
1 |
Maiss (šķīdinātājs), 1600 ml |
-
|
|
|
Ingelvac Ery emulsija injekcijām cūkām
|
-
|
V/DCP/21/0030
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI09AB03
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Erysipelothrix rhusiopathiae, serotype 2, strain SE-9, Inactivated
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
LABORATORIOS SYVA, S.A.U. , Spānija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 08042024_LI (08-Apr-2024)
|
| Labelling text: |
[DOCX] 19122022_M (19-Dec-2022)
|
| Summary of product characteristics: |
[DOCX] 19122022_ZA (19-Dec-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0030-01 |
|
1 |
Polipropilēna flakons, 100 ml |
-
|
|
|
Thyrovet
|
800 µg
|
V/DCP/24/0008
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QH03AA01
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/24/0008-01 |
800 µg/tabl. |
3 |
AL/PVC-AL-PA blisteris, 10 tablete |
-
|
| V/DCP/24/0008-02 |
800 µg/tabl. |
10 |
AL/PVC-AL-PA blisteris, 10 tablete |
-
|
|
|
Rodotium
|
162 mg/ml
|
V/MRP/24/0022
|
Huvepharma EOOD, Bulgārija
|
QJ01XQ01
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/24/0022-01 |
|
1 |
Stikla pudele, 100 ml |
-
|
|
|
Equisedan
|
10 mg/ml
|
V/MRP/13/0033
|
Vetcare Oy, Somija
|
QN05CM90
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Detomidine hydrochloride
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Laboratorios SYVA S.A.U, Spānija;Tairgi Tread-Lia Baile na Sceilge Teo (Trading as Ballinskelligs Veterinary Products), Īrija
|
| Date of authorisation/renewal: |
30-Oct-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2025)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2025)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/13/0033-01 |
10 mg/ml |
1 |
Stikla flakons, 10 ml |
-
|
| V/MRP/13/0033-02 |
10 mg/ml |
1 |
Stikla flakons, 15 ml |
-
|
|
|
Equibactin vet.
|
-
|
V/DCP/19/0040
|
Dechra Regulatory B.V., Nīderlande
|
QJ01EW10
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
oral powder
|
| International name (active substance): |
Sulfadiazine, Trimethoprim
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] 02082019LI (02-Aug-2019)
|
| Labelling text: |
[PDF] 02082019M (02-Aug-2019)
|
| Summary of product characteristics: |
[PDF] 02082019ZA (02-Aug-2019)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/19/0040-01 |
250/50 mg |
1 |
ABPE trauciņš, 105 g |
-
|
| V/DCP/19/0040-02 |
250/50 mg |
1 |
ABPE trauciņš, 210 g |
-
|
| V/DCP/19/0040-03 |
250/50 mg |
1 |
ABPE trauciņš, 420 g |
-
|
| V/DCP/19/0040-04 |
250/50 mg |
1 |
Polipropilēna trauciņš, 840 g |
-
|
| V/DCP/19/0040-05 |
250/50 mg |
10 |
PET/AL/PE maisiņš, 5 g |
-
|
| V/DCP/19/0040-06 |
250/50 mg |
20 |
PET/AL/PE maisiņš, 5 g |
-
|
| V/DCP/19/0040-07 |
250/50 mg |
28 |
PET/AL/PE maisiņš, 5 g |
-
|
| V/DCP/19/0040-08 |
250/50 mg |
10 |
PET/AL/PE maisiņš, 15 g |
-
|
| V/DCP/19/0040-09 |
250/50 mg |
20 |
PET/AL/PE maisiņš, 15 g |
-
|
| V/DCP/19/0040-10 |
250/50 mg |
28 |
PET/AL/PE maisiņš, 15 g |
-
|
| V/DCP/19/0040-12 |
250/50 mg |
10 |
PET/AL/PE maisiņš, 30 g |
-
|
| V/DCP/19/0040-13 |
250/50 mg |
20 |
PET/AL/PE maisiņš, 30 g |
-
|
| V/DCP/19/0040-14 |
250/50 mg |
28 |
PET/AL/PE maisiņš, 30 g |
-
|
| V/DCP/19/0040-16 |
250/50 mg |
10 |
PET/AL/PE maisiņš, 60 g |
-
|
| V/DCP/19/0040-17 |
250/50 mg |
20 |
PET/AL/PE maisiņš, 60 g |
-
|
| V/DCP/19/0040-18 |
250/50 mg |
28 |
PET/AL/PE maisiņš, 60 g |
-
|
| V/DCP/19/0040-20 |
250/50 mg |
10 |
PET/AL/PE maisiņš, 100 g |
-
|
|
|
Versiguard Rabies
|
-
|
V/MRP/06/1668
|
Zoetis Belgium S.A., Beļģija
|
QI07AA02
|
ferrets; cattle; pigs; sheep; goats; horses; dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/06/1668-01 |
|
10 |
Flakons, 1 deva |
-
|
| V/MRP/06/1668-12 |
|
10 |
Flakons, 10 deva |
-
|
| V/MRP/06/1668-16 |
|
1 |
Flakons, 1 deva |
-
|
|
|
Lineomam LC
|
-
|
V/MRP/17/0024
|
Bioveta, a.s., Čehija
|
QJ51RF03
|
cattle (lactating cows)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary solution
|
| International name (active substance): |
Lincomycin hydrohloride, Neomycin sulphate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
24-Feb-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 230221LI (24-Feb-2021)
|
| Labelling text: |
[DOCX] 230221M (24-Feb-2021)
|
| Summary of product characteristics: |
[DOCX] 300523ZA (31-May-2023)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/17/0024-01 |
|
24 |
Injektors, 10 ml |
-
|
|
|
Profexx
|
50 mg/ml
|
V/DCP/24/0025
|
Alfasan Nederland BV, Nīderlande
|
QM01AE91
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/24/0025-01 |
|
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/24/0025-02 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/24/0025-03 |
|
1 |
Stikla flakons, 250 ml |
-
|
|
|
Cartaxx
|
50 mg/ml
|
V/DCP/24/0026
|
Alfasan Nederland BV, Nīderlande
|
QM01AE91
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/24/0026-01 |
|
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/24/0026-02 |
|
1 |
Stikla flakons, 20 ml |
-
|
| V/DCP/24/0026-03 |
|
1 |
Stikla flakons, 50 ml |
-
|
|
|
Nobivac Tricat Trio
|
-
|
V/MRP/07/1709
|
Intervet International B.V., Nīderlande
|
QI06AD04
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live attenuated feline rhinotracheitis virus, strain G2620A,Live, attenuated feline calici virus,Live attenuated feline panleucopenia virus
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
07-Oct-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Jan-2023)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Jan-2023)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (24-Jan-2023)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/07/1709-01 |
|
5 |
Stikla flakons (kartona kastē), 1 deva |
-
|
| V/MRP/07/1709-02 |
|
10 |
Stikla flakons (kartona kastē), 1 deva |
-
|
| V/MRP/07/1709-03 |
|
25 |
Stikla flakons (kartona kastē), 1 deva |
-
|
| V/MRP/07/1709-04 |
|
50 |
Stikla flakons (kartona kastē), 1 deva |
-
|
| V/MRP/07/1709-05 |
|
5 |
Stikla flakons (plastikāta kastē), 1 deva |
-
|
| V/MRP/07/1709-06 |
|
10 |
Stikla flakons (plastikāta kastē), 1 deva |
-
|
| V/MRP/07/1709-07 |
|
25 |
Stikla flakons (plastikāta kastē), 1 deva |
-
|
| V/MRP/07/1709-08 |
|
50 |
Stikla flakons (plastikāta kastē), 1 deva |
-
|
|
|
Nobivac Pi
|
-
|
V/MRP/22/0003
|
Intervet International B.V., Nīderlande
|
QI07AD08
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/22/0003-01 |
|
5 |
Stikla flakons, 1 deva |
-
|
| V/MRP/22/0003-02 |
|
10 |
Stikla flakons, 1 deva |
-
|
| V/MRP/22/0003-03 |
|
25 |
Stikla flakons, 1 deva |
-
|
| V/MRP/22/0003-04 |
|
50 |
Stikla flakons, 1 deva |
-
|
|
|
Oxytocin 10 IU/ml
|
10 IU/ml
|
V/NRP/96/0314
|
Bela-pharm GmbH&Co.KG, Vācija
|
QH01BB02
|
cattle; pigs; sheep; goats; horses; dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/96/0314-01 |
16,6 µg/ml |
1 |
Stikla flakons, 10 ml |
-
|
| V/NRP/96/0314-02 |
16,6 µg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/NRP/96/0314-03 |
16,6 µg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/96/0314-04 |
16,6 µg/ml |
5 |
Stikla flakons, 10 ml |
-
|
| V/NRP/96/0314-05 |
16,6 µg/ml |
6 |
Stikla flakons, 10 ml |
-
|
| V/NRP/96/0314-06 |
16,6 µg/ml |
10 |
Stikla flakons, 10 ml |
-
|
| V/NRP/96/0314-07 |
16,6 µg/ml |
12 |
Stikla flakons, 10 ml |
-
|
| V/NRP/96/0314-08 |
16,6 µg/ml |
6 |
Stikla flakons, 50 ml |
-
|
| V/NRP/96/0314-09 |
16,6 µg/ml |
12 |
Stikla flakons, 50 ml |
-
|
| V/NRP/96/0314-10 |
16,6 µg/ml |
6 |
Stikla flakons, 100 ml |
-
|
| V/NRP/96/0314-11 |
16,6 µg/ml |
12 |
Stikla flakons, 100 ml |
-
|
|
|
Alpramil
|
mg
|
V/DCP/22/0018
|
Alfasan Nederland BV, Nīderlande
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0018-01 |
|
1 |
Al/OPA/Al/PVH blisteris, 1 tablete |
-
|
| V/DCP/22/0018-02 |
|
1 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/22/0018-03 |
|
1 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
| V/DCP/22/0018-04 |
|
10 |
Al/OPA/Al/PVH blisteris, 1 tablete |
-
|
| V/DCP/22/0018-05 |
|
10 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/22/0018-06 |
|
10 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
| V/DCP/22/0018-07 |
|
25 |
Al/OPA/Al/PVH blisteris, 1 tablete |
-
|
| V/DCP/22/0018-08 |
|
25 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/22/0018-09 |
|
25 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
|
|
Alpramil
|
mg
|
V/DCP/22/0019
|
Alfasan Nederland BV, Nīderlande
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0019-01 |
|
1 |
Al/OPA/Al/PVH blisteris, 1 tablete |
-
|
| V/DCP/22/0019-02 |
|
1 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/22/0019-03 |
|
1 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
| V/DCP/22/0019-04 |
|
10 |
Al/OPA/Al/PVH blisteris, 1 tablete |
-
|
| V/DCP/22/0019-05 |
|
10 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/22/0019-06 |
|
10 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
| V/DCP/22/0019-07 |
|
25 |
Al/OPA/Al/PVH blisteris, 1 tablete |
-
|
| V/DCP/22/0019-08 |
|
25 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/22/0019-09 |
|
25 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
|
|
Alpramil
|
mg
|
V/DCP/22/0020
|
Alfasan Nederland BV, Nīderlande
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0020-01 |
|
1 |
Al/OPA/Al/PVH blisteris, 1 tablete |
-
|
| V/DCP/22/0020-02 |
|
1 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/22/0020-03 |
|
1 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
| V/DCP/22/0020-04 |
|
10 |
Al/OPA/Al/PVH blisteris, 1 tablete |
-
|
| V/DCP/22/0020-05 |
|
10 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/22/0020-06 |
|
10 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
| V/DCP/22/0020-07 |
|
25 |
Al/OPA/Al/PVH blisteris, 1 tablete |
-
|
| V/DCP/22/0020-08 |
|
25 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/22/0020-09 |
|
25 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
|
|
Alpramil
|
mg
|
V/DCP/22/0021
|
Alfasan Nederland BV, Nīderlande
|
QP54AB51
|
cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0021-01 |
|
1 |
alumīnija/PVC/PE/PVDC blisteris, 1 tablete |
-
|
| V/DCP/22/0021-02 |
|
1 |
alumīnija/PVC/PE/PVDC blisteris, 2 tablete |
-
|
| V/DCP/22/0021-03 |
|
1 |
alumīnija/PVC/PE/PVDC blisteris, 4 tablete |
-
|
| V/DCP/22/0021-04 |
|
10 |
alumīnija/PVC/PE/PVDC blisteris, 1 tablete |
-
|
| V/DCP/22/0021-05 |
|
10 |
alumīnija/PVC/PE/PVDC blisteris, 2 tablete |
-
|
| V/DCP/22/0021-06 |
|
10 |
alumīnija/PVC/PE/PVDC blisteris, 4 tablete |
-
|
| V/DCP/22/0021-07 |
|
25 |
alumīnija/PVC/PE/PVDC blisteris, 1 tablete |
-
|
| V/DCP/22/0021-08 |
|
25 |
alumīnija/PVC/PE/PVDC blisteris, 2 tablete |
-
|
| V/DCP/22/0021-09 |
|
25 |
alumīnija/PVC/PE/PVDC blisteris, 4 tablete |
-
|
|
|
Tulaject
|
100 mg/ml
|
V/DCP/20/0059
|
Alivira Animal Health Limited;, Īrija
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0059-01 |
100 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/20/0059-02 |
100 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/20/0059-03 |
100 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
|
|
ReproCyc PRRS EU
|
-
|
V/DCP/15/0007
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI09AD03
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live attenuated porcine reproductive and respiratory syndrome virus, strain 94881
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Pharma GmbH & Co. KG, Vācija
|
| Date of authorisation/renewal: |
28-Apr-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Oct-2025)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Oct-2025)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (24-Oct-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0007-01 |
|
1 |
Stikla flakons, 10 deva |
-
|
| V/DCP/15/0007-02 |
|
1 |
Stikla flakons, 50 deva |
[PDF]
[PDF]
[DOCX]
|
| V/DCP/15/0007-03 |
|
1 |
Stikla flakons, 100 deva |
-
|
| V/DCP/15/0007-04 |
|
12 |
Stikla flakons, 10 deva |
-
|
| V/DCP/15/0007-05 |
|
25 |
Stikla flakons, 10 deva |
-
|
| V/DCP/15/0007-06 |
|
12 |
Stikla flakons, 50 deva |
-
|
| V/DCP/15/0007-07 |
|
25 |
Stikla flakons, 50 deva |
-
|
| V/DCP/15/0007-08 |
|
12 |
Stikla flakons, 100 deva |
-
|
| V/DCP/15/0007-09 |
|
25 |
Stikla flakons, 100 deva |
-
|
|
|
Novasul
|
500 mg/ml
|
V/NRP/97/0557
|
VetViva Richter GmbH , Austrija
|
QN02BB02
|
cattle; pigs; horses; dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/97/0557-01 |
500 mg/ml |
1 |
Stikla flakons ar bromobutila aizbāzni, 100 ml |
-
|
|